Prescription drug · NDA
Qvar Redihaler (beclomethasone dipropionate hfa) NDC 50090-5032
Beclomethasone dipropionate 80 ug/1 · Aerosol, Metered · Respiratory (Inhalation) · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-5032-0 | 50090503200 | 1 INHALER in 1 CARTON (50090-5032-0) / 1 AEROSOL, METERED in 1 INHALERMarketed from Apr 30, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Qvar Redihaler
- Generic name (nonproprietary)
- beclomethasone dipropionate hfa
- Active ingredients
- Beclomethasone dipropionate — 80 ug/1
- Dosage form
- Aerosol, Metered
- Route
- Respiratory (Inhalation)
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 207921
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 50090-5032_778908c5-aa3d-496b-b530-9a5da5eebc6cSPL ID 778908c5-aa3d-496b-b530-9a5da5eebc6cSPL set ID 2814cf81-392e-4dd4-9816-ae7e6e5ec84fRxCUI 1998771, 1998772UNII 5B307S63B2
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090503200followed by a unit qualifier and the quantityPackage 50090-5032-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
QVAR REDIHALER is indicated in the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. Limitations of Use: QVAR REDIHALER is not indicated for the relief of acute bronchospasm. QVAR REDIHALER is a corticosteroid indicated for maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. ( 1 ) Limitations of Use : Not indicated for the relief of acute bronchospasm. ( 1 )
Excerpt only. Read the full label for complete information.